Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02362308 · ClinicalTrials.gov registry record
Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 10
- Enrollment target
NCT02362308 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 10 participants.
The verdict
NCT02362308 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This observational study tests the hypothesis that endogenous aldosterone impairs insulin secretion and insulin sensitivity in subjects with primary aldosteronism.
Interventions
- OTHER Adrenalectomy
- DRUG mineralocorticoid receptor antagonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-01 |
| Est. Completion | 2020-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02362308
The ClinicalTrials.gov registry entry for NCT02362308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adrenalectomy is the first listed.
NCT02362308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02362308 about?
NCT02362308 is a clinical study titled "Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas". This observational study tests the hypothesis that endogenous aldosterone impairs insulin secretion and insulin sensitivity in subjects with primary aldosteronism.
What is the current status of trial NCT02362308?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2015-01. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02362308?
The interventions under investigation include: Adrenalectomy (OTHER), mineralocorticoid receptor antagonist (DRUG).
Who is sponsoring clinical trial NCT02362308?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.